Deal-Making

thumbnail
Deal-Making
Halozyme eyes continuous manufacturing platform in $2.1bn Evotec bidHalozyme eyes continuous manufacturing platform in $2.1bn Evotec bid

The proposed acquisition of Evotec would essentially transform Halozyme from a therapeutics-based drug delivery platform into a full bioprocess services company.

byDan Stanton
Nov 22, 2024
|
1 Min Read
thumbnail
Deal-Making
CDMO success stories: News from Lonza, Samsung Bio, FujifilmCDMO success stories: News from Lonza, Samsung Bio, Fujifilm
byDan Stanton
Nov 21, 2024
1 Min Read
thumbnail
Facilities & Capacity
Affinia and Forge team up to tackle cardiovascular diseasesAffinia and Forge team up to tackle cardiovascular diseases
byJosh Abbott
Nov 15, 2024
1 Min Read
thumbnail
Therapeutic Class
Meitheal adds three biosimilars to US offering with new agreementMeitheal adds three biosimilars to US offering with new agreement
byJosh Abbott
Nov 13, 2024
1 Min Read
thumbnail
Deal-Making
Novo taps Ascendis in $285m GLP-1 dealNovo taps Ascendis in $285m GLP-1 deal
byShreeyashi Ojha
Nov 13, 2024
1 Min Read
thumbnail
Deal-Making
PE to buy CDMO Avid Bioservices for $1.1 billionPE to buy CDMO Avid Bioservices for $1.1 billion
byDan Stanton
Nov 7, 2024
1 Min Read
Deal-Making
Chime partners with MedPacto for biologic manufacturing
Chime partners with MedPacto for biologic manufacturing
Nov 4, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Oct 30, 2024
|
1 Min Read
byShreeyashi Ojha
Regulations
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Oct 18, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Oct 16, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
Oct 14, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Opencell and Adva partnership seeks to improve CGT manufacturing
Opencell and Adva partnership seeks to improve CGT manufacturing
Oct 9, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Recipharm and Exela collaborate to boost US sterile injectable production
Recipharm and Exela collaborate to boost US sterile injectable production
Oct 9, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Xcellbio and AmplifyBio partner to advance cell-therapy development
Xcellbio and AmplifyBio partner to advance cell-therapy development
Oct 8, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Oct 4, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Oct 3, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Oct 2, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
CompleCure taps AGC for AMDC-based cancer-therapy development
CompleCure taps AGC for AMDC-based cancer-therapy development
Sep 30, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Sep 26, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Charles River and Ori Biotech collaborate on CAR-T production
Charles River and Ori Biotech collaborate on CAR-T production
Sep 20, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
Sep 19, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa
Bavarian Nordic to send 500,000 doses of mpox vaccine to Africa
Sep 19, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Kincell secures partnership to produce cell therapy for clinical trials
Kincell secures partnership to produce cell therapy for clinical trials
Sep 17, 2024
|
1 Min Read
byShreeyashi Ojha
Facilities & Capacity
Hongene and ReciBioPharm partner to improve gene-editing services
Hongene and ReciBioPharm partner to improve gene-editing services
Sep 16, 2024
|
1 Min Read
byJosh Abbott, Shreeyashi Ojha
Deal-Making
Cellular and 3P partner to bolster CGT manufacturing
Cellular and 3P partner to bolster CGT manufacturing
Sep 13, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Cellares and Sony partner to automate cell therapy manufacturing
Cellares and Sony partner to automate cell therapy manufacturing
Sep 12, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Boehringer Ingelheim bolsters veterinary pipeline with Saiba acquisition
Boehringer Ingelheim bolsters veterinary pipeline with Saiba acquisition
Sep 5, 2024
|
1 Min Read
byJosh Abbott
Deal-Making
Bora expands CDMO offering with Tanvex buy
Bora expands CDMO offering with Tanvex buy
Aug 30, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
AstraZeneca denies ‘Brexit’ rumors
AstraZeneca denies ‘Brexit’ rumors
Aug 30, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Vion bolsters mRNA therapy portfolio with Echelon acquisition
Vion bolsters mRNA therapy portfolio with Echelon acquisition
Aug 28, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Agilent on ‘rich’ RNA outsourcing space as Biovectra buy beckons
Agilent on ‘rich’ RNA outsourcing space as Biovectra buy beckons
Aug 26, 2024
|
1 Min Read
byDan Stanton
Deal-Making
ST Pharm taps Quantoom to bolster mRNA supply
ST Pharm taps Quantoom to bolster mRNA supply
Aug 22, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Germfree, Caring Cross to bring affordable CAR-Ts to Brazil
Germfree, Caring Cross to bring affordable CAR-Ts to Brazil
Aug 21, 2024
|
1 Min Read
byShreeyashi Ojha
Bioprocess Insider
Reuters reports Repligen offer to buy Maravai LifeSciences
Reuters reports Repligen offer to buy Maravai LifeSciences
Aug 16, 2024
|
1 Min Read
byJosh Abbott
Bioprocess Insider
Merck secures antibody in $700m Curon deal
Merck secures antibody in $700m Curon deal
Aug 13, 2024
|
1 Min Read
byShreeyashi Ojha

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024